Biodesix
BDSX
47 hedge funds and large institutions have $75.4M invested in Biodesix in 2020 Q4 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.71% more ownership
Funds ownership: 0% → 0.71% (+0.71%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Birchview Capital
Burlington,
Vermont
|
+$17.2M |
| 2 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
+$7.46M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$5.04M |
| 4 |
Millennium Management
New York
|
+$4.38M |
| 5 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$3.67M |
Top Sellers
BDSX Hedge Fund Activity: Q4 2020 in Review
47 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q4 2020, worth a combined $75.4M.
Buyers outnumbered sellers: 47 funds opened new BDSX positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Birchview Capital, opening a new position worth an estimated $17.2M.
- 47 institutional investors held Biodesix (BDSX) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $75.4M of Biodesix stock for Q4 2020.
- 47 funds opened new Biodesix positions in Q4 2020 and 0 closed out, a net change of +47 holders.
- The largest Biodesix buyer in Q4 2020 was Birchview Capital, an estimated $17.2M added.
Based on aggregated 13F filings for Q4 2020.